People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeutics Inc. | — | Biotechnology | Series A | $12.3M | $379.6M | 2012 |
Adrian S. Harel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adrian S. Harel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chen Schor | 1 | 4 |
| Irit Arbel | 1 | 2 |
| Robert Shorr | 1 | 2 |
| Alon Pinkas | 1 | 1 |
| Chaim S. Lebovits | 1 | 1 |
| Anthony S. Fiorino | 1 | 1 |
| Mordechai S. Friedman | 1 | 1 |
| Uri S. Yablonka | 1 | 1 |
| Malcolm Taub | 1 | 1 |
| Chaim Lebovits | 1 | 1 |
| Mordechai Friedman | 1 | 1 |
| Abraham Israeli | 1 | 1 |
| Malcolm S. Taub | 1 | 1 |
| Liat Sossover | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.